Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Slevin

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The British Journal of Radiology|February 18, 2009
A novel imaging technique for fusion of high-quality immobilised MR images of the head and neck with CT scans for radiotherapy target delineationG J Webster, J E Kilgallon, K F Ho, et al.
British Journal of Cancer|January 1, 1997
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 casesS S Susnerwala, J H Shanks, S S Banerjee, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|September 22, 2007
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a reviewP Silva, J J Homer, N J Slevin, et al.
British Journal of Cancer|July 2, 1998
The in vitro radiosensitivity of human head and neck cancersT Björk-Eriksson, C M West, E Karlsson, et al.
The Journal of Laryngology and Otology|April 15, 2010
Use of multiple biological markers in radiotherapy-treated head and neck cancerP Silva, N J Slevin, P Sloan, et al.
Head & Neck|September 26, 2000
Metastatic renal cell carcinoma to the nose and paranasal sinusesR Simo, A J Sykes, S P Hargreaves, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 7, 2013
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinomaK K Oguejiofor, J S Hall, N Mani, et al.
British Journal of Cancer|January 5, 2001
Randomized controlled trial to assess the effectiveness of a videotape about radiotherapyR Harrison, P Dey, N J Slevin, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The British Journal of Radiology|February 18, 2009
A novel imaging technique for fusion of high-quality immobilised MR images of the head and neck with CT scans for radiotherapy target delineationG J Webster, J E Kilgallon, K F Ho, et al.
British Journal of Cancer|January 1, 1997
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 casesS S Susnerwala, J H Shanks, S S Banerjee, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|September 22, 2007
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a reviewP Silva, J J Homer, N J Slevin, et al.
British Journal of Cancer|July 2, 1998
The in vitro radiosensitivity of human head and neck cancersT Björk-Eriksson, C M West, E Karlsson, et al.
The Journal of Laryngology and Otology|April 15, 2010
Use of multiple biological markers in radiotherapy-treated head and neck cancerP Silva, N J Slevin, P Sloan, et al.
Head & Neck|September 26, 2000
Metastatic renal cell carcinoma to the nose and paranasal sinusesR Simo, A J Sykes, S P Hargreaves, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 7, 2013
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinomaK K Oguejiofor, J S Hall, N Mani, et al.
British Journal of Cancer|January 5, 2001
Randomized controlled trial to assess the effectiveness of a videotape about radiotherapyR Harrison, P Dey, N J Slevin, et al.
Pageof 7